Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (34)

2025

  1. Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data

    Cancer Immunology, Immunotherapy, Vol. 74, Núm. 4

2024

  1. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  2. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  3. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  5. Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

    Archivos de Bronconeumologia, Vol. 60, pp. S67-S76

  6. Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer

    ERJ Open Research, Vol. 10, Núm. 1

  7. The tip of the iceberg: a plethora of lung nodules in the general population

    The European respiratory journal

2023

  1. Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union’s new recommendations on lung cancer screening

    ERJ Open Research

  2. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

    Journal of Translational Medicine, Vol. 21, Núm. 1

  3. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  4. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  5. Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent

    Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3499-3507

2022

  1. Deep learning-based lesion subtyping and prediction of clinical outcomes in COVID-19 pneumonia using chest CT

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Molecular biomarkers in early stage lung cancer

    Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185

  2. Present, past, and future of the connection between SAHS and cancer

    Open Respiratory Archives

  3. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. Screening in Lung Cancer: The Latest Evidence

    Archivos de Bronconeumologia, Vol. 56, Núm. 1, pp. 7-8

2019

  1. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357

  2. Inhaled Corticosteroids and Lung Cancer in COPD

    Archivos de Bronconeumologia